Heparin and Gene Microarrays as a New Pharmacodynamic Tool
Lists
Only you see this
Abstract
Traditionally the effect of a drug on a tissue is measured by methods that are either limited in scope or in information. Individual protein and mRNA levels measured by Northern and Western blotting or by Immunohistochemistry, while demonstrating an effect and providing some mechanistic description provide information only on those targeted molecules. Likewise, morphometric analyses of tissues examine the gross tissue response, but provide little insight into the underlying mechanisms responsible for the present state of the tissue. Gene micro-arrays allow the screening of thousands of mRNA expression levels in a single sample. This technique therefore yields data that is both tissue wide in scope and mechanistic in nature. This becomes especially useful when the drug being examined has effects beyond that of the desired effect. In this chapter, Heparin and its ability to inhibit intimal hyperplasia following arterial injury will serve as an example of a disease and intervention where gene microarrays can be applied as a new pharmacodynamic tool. Heparin's function as an anticoagulant is well described, but it is also known to possess numerous other functions that are less well understood. It is both the pleiotropic effects of Heparin and the complexity of vascular disease that make this an ideal situation for the use of gene microarrays to monitor the efficacy of an drug delivery method.
BibTeX
@inproceedings{woods2003heparin,
author = {T. Cooper Woods and Chad R. Blystone and Morris J. Karnovsky and Elazer R. Edelman},
title = {{Heparin and Gene Microarrays as a New Pharmacodynamic Tool}},
booktitle = {ACS},
year = {2003},
doi = {10.1021/bk-2003-0846.ch002},
}Loading related content...